Yihua Wang Selected Research

Chitosan

1/2021

Chitosan Oligosaccharide Ameliorates Metabolic Syndrome Induced by Overnutrition via Altering Intestinal Microbiota.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yihua Wang Research Topics

Disease

33	Neoplasms (Cancer) 06/2022 - 09/2005
11	Breast Neoplasms (Breast Cancer) 05/2022 - 10/2016
8	Hypoxia (Hypoxemia) 01/2022 - 04/2015
7	Carcinogenesis 01/2022 - 03/2005
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 12/2016
6	Esophageal Squamous Cell Carcinoma 11/2008 - 03/2005
5	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2014
5	Esophageal Neoplasms (Esophageal Cancer) 11/2010 - 09/2005
4	Triple Negative Breast Neoplasms 09/2021 - 11/2020
2	Fibrosis (Cirrhosis) 01/2022 - 01/2021
2	Lung Neoplasms (Lung Cancer) 01/2021 - 12/2016
2	COVID-19 01/2021 - 01/2020
2	Parasitic Diseases (Parasitic Disease) 11/2020 - 01/2018
2	Cerebral Infarction 01/2020 - 09/2018
2	Intracranial Vasospasm 12/2019 - 06/2018
2	Hepatocellular Carcinoma (Hepatoma) 07/2015 - 04/2015
2	Multiple Myeloma 02/2013 - 01/2012
1	Reperfusion Injury 01/2022
1	Inflammation (Inflammations) 01/2022
1	Chemical and Drug Induced Liver Injury 01/2022
1	Diabetes Mellitus 01/2022
1	Atherosclerosis 01/2022
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 10/2021
1	Hypercholesterolemia 04/2021
1	Pulmonary Alveolar Proteinosis 04/2021
1	Dyspnea (Shortness of Breath) 04/2021
1	Pathologic Complete Response 02/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Overnutrition 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Disease Progression 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Rhabdomyolysis 01/2021

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2004
8	beta CateninIBA 01/2020 - 03/2005
6	Cadherins (E-Cadherin)IBA 01/2021 - 06/2005
5	LipidsIBA 04/2021 - 09/2018
4	CateninsIBA 01/2021 - 11/2014
3	Biological ProductsIBA 06/2022 - 01/2021
3	Oxygen (Dioxygen)IBA 01/2022 - 02/2020
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2017
3	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2016
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2006
3	Caspase 3 (Caspase-3)IBA 01/2020 - 09/2018
3	Polysaccharides (Glycans)IBA 10/2016 - 04/2015
2	Hormones (Hormone)IBA 05/2022 - 02/2021
2	Mixed Function Oxygenases (Monooxygenases)IBA 01/2022 - 11/2018
2	VimentinIBA 10/2021 - 12/2016
2	Docetaxel (Taxotere)FDA Link 09/2021 - 07/2021
2	Progesterone Receptors (Progesterone Receptor)IBA 02/2021 - 11/2020
2	Phenobarbital (Luminal)FDA Link 01/2021 - 07/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2019
2	ElementsIBA 01/2021 - 08/2008
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 09/2018
2	MethyltransferasesIBA 01/2020 - 01/2018
2	AntagomirsIBA 01/2020 - 09/2018
2	Pharmaceutical PreparationsIBA 01/2020 - 08/2014
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 12/2019 - 06/2018
2	huaierIBA 10/2016 - 04/2015
2	Matrix Metalloproteinases (MMPs)IBA 07/2015 - 04/2015
2	brucineIBA 02/2013 - 01/2012
2	SurvivinIBA 05/2009 - 09/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	CollagenIBA 01/2022
1	Ubiquitin-Specific Peptidase 7IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	ThrombomodulinIBA 01/2022
1	Liver X ReceptorsIBA 01/2022
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022
1	ApolipoproteinsIBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 10/2021
1	Fibrinogen (Factor I)FDA Link 05/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2021
1	Atorvastatin (Lipitor)FDA Link 04/2021
1	Surface-Active Agents (Surfactants)IBA 04/2021
1	CurcuminIBA 01/2021
1	pamiparibIBA 01/2021
1	OligosaccharidesIBA 01/2021
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	PolymersIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	ChitosanIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021

Therapy/Procedure

14	Therapeutics 05/2022 - 08/2014
7	Neoadjuvant Therapy 05/2022 - 07/2018
2	Stents 11/2020 - 10/2015
1	Precision Medicine 01/2022
1	Liver Transplantation 01/2022
1	Craniotomy 10/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021